Statewide episode spending variation of thyroidectomy for lower-risk thyroid cancer - 29/01/26
, Steven Xie a, Aayushi Sinha a, Elizabeth M. Bacon a, Hunter J. Underwood a, Hari Nathan a, Susan C. Pitt aAbstract |
Background |
This study aimed to evaluate variation in spending for thyroidectomy for patients with thyroid cancer.
Methods |
This retrospective cohort study analyzed risk-adjusted, price-standardized Michigan-based claims data from 2015 to 2022 and included patients who underwent thyroidectomy for lower-risk thyroid cancer. The primary outcome was 90-day spending. A mixed linear model with facility as a random effect identified factors associated with spending variability.
Results |
In total, 2516 patients underwent thyroidectomy at 81 facilities. Unadjusted 90-day spending ranged from $5917 to $25,630 across facilities (median $8993). Spending was lowest for lobectomy (median $7755) and highest for lobectomy followed by completion thyroidectomy (median $14,181). On regression, factors significantly associated with increased spending were patient age and readmission. The interaction between occurrence of post-operative complications and lengths of stay >2 nights contributed to dramatically higher spending.
Conclusions |
Reducing complications and associated length of stay as well hospital readmissions represent opportunities to improve the value of thyroidectomy.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Variation exists in 90-day spending for thyroidectomy for lower-risk thyroid cancer. |
• | Post-op complications, length of stay, and readmission are drivers of spending. |
• | Facility-level thyroidectomy volume is not significantly associated with spending. |
Keywords : Thyroid cancer, Thyroidectomy, Spending variability, Episode spending, Value-based care
Plan
Vol 253
Article 116816- mars 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
